PreveCeutical Applies to List on the TSX Venture Exchange as a Tier 2 Issuer
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has filed an application to list its common shares on the TSX Venture Exchange (the "TSX-V") as a tier 2 issuer. About PreveCeutical Medical Inc.PreveCeutical is a health sciences company that develops innovative preventive therapies utilizing organic and nature identical products.PreveCeutical aims...
2017-09-25 3:05 AM EDT
PreveCeutical Announces Strategic R&D Supply Agreement
Vancouver, British Columbia--(Newsfile Corp. - September 21, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that it has entered into a strategic research and development supply agreement dated effective September 18, 2017 (the "Supply Agreement") with a licensed producer of medical cannabis (the "LP") under Health Canada's Access to Cannabis for Medical Purposes Regulations, whereby the LP will supply samples...
2017-09-21 3:05 AM EDT
PreveCeutical Begins Trading on the OTCQB Venture Marketplace
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company's application to have its common shares listed on the OTCQB Venture Marketplace ("OTCQB") in the United States has been approved and that the Company's common share began trading on September 15, 2017, under the symbol "PRVCF". The OTCQB is for early-stage and developing United States and...
2017-09-18 3:05 AM EDT
PreveCeutical Launches New Corporate Website
Vancouver, British Columbia--(Newsfile Corp. - September 15, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTC Pink: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce the launch of a new corporate website - www.PreveCeutical.com. The new website has been optimized to cater to both desktop and mobile users. In an organized layout, visitors across all platforms are able to efficiently access information on PreveCeutical's innovative research and development programs,...
2017-09-15 3:05 AM EDT
PreveCeutical Engages the Susan Blond Group Inc. for Publicity Services and Appoints Ms. Susan Blond as Director of Publicity
Vancouver, British Columbia--(Newsfile Corp. - September 13, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTC Pink: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the engagement of the Susan Blond Group Inc. (the "Susan Blond Group") to provide publicity services and the appointment of Ms. Susan Blond as the Company's Director of Publicity. Ms. Blond, principal of the Susan Blond Group, will assist PreveCeutical in initiating, implementing and executing the Company's...
2017-09-13 3:05 AM EDT
PreveCeutical(TM) Medical and Sports 1 Marketing Announce Joint Venture to Develop a Therapy for Concussions
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTC Pink: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), and Sports 1 Marketing ("S1M") announces a joint venture to develop a therapy geared towards athletes who suffer from concussions (Mild Traumatic Brain Injury) ("TBI").Through PreveCeutical's current Research and Development ("R&D") program connected to the Caribbean Blue Scorpion venom, PreveCeutical and S1M believe that...
2017-08-30 3:05 AM EDT
PreveCeutical(TM) Medical Begins Trading on the OTC Market
Vancouver, British Columbia--(Newsfile Corp. - August 16, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTC Pink: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the quotation of its common shares for trading on the OTC Pink market, under the symbol "PRVCF".In connection with the quotation of its shares on the OTC, the Company is completing its filings for the quotation of its shares on the OTCQB market. The Company has also made an application for its common shares...
2017-08-16 3:05 AM EDT
PreveCeutical(TM) Medical Inc. Announces Requisitions to Acquire State-of-the-Art Instrumentation Expediting Suite of Research and Developments Programs
Vancouver, British Columbia--(Newsfile Corp. - August 14, 2017) - PreveCeutical™ Medical Inc. (CSE: PREV) (FSE: 18H) (the "Company" or "PreveCeutical") announces the Company has acquired four new key instruments to assist in expediting PreveCeutical's current pipeline of innovative Research and Development Programs (R&D). PreveCeutical anticipates delivery and commissioning of all four systems in the next four to six weeks.R&D ProgramsDual Gene TherapyThis program paves the way for...
2017-08-14 3:05 AM EDT